Menu
Oops! This video is not supported on your web browser
To continue streaming, we recommend using the latest version of Chrome or Firefox.
Access expanding for experimental weight loss drug
2M
Drugmaker Eli Lilly says it is expanding access to its experimental weight loss drug, retatrutide, which has not been approved yet by the FDA. The ...
Streaming Weekdays
Menu
You’ve reached the maximum number of streams allowed with your subscription.
To view this video, close the other videos you’re watching and try again.
Retry
Access expanding for experimental weight loss drug
2M
Drugmaker Eli Lilly says it is expanding access to its experimental weight loss drug, retatrutide, which has not been approved yet by the FDA. The ...
Streaming Weekdays